Huang I-Fei, Wagener Marilyn M, Hsieh Kai-Sheng, Liu Yung-Ching, Wu Tzee-Chung, Lee Wei-Yang, Chiou Christine C
Department of Pediatrics, Veterans General Hospital, Kaohsiung, Taiwan.
J Pediatr Gastroenterol Nutr. 2004 May;38(5):518-23. doi: 10.1097/00005176-200405000-00011.
The purposes of this study were to investigate the epidemiologic, clinical, and microbiologic features of patients with nontyphoid salmonellosis and to elucidate the impact of resistance on the outcome of nontyphoid salmonellosis in Taiwan. The authors also sought to develop a severity score to derive an objective guideline for antibiotic use in nontyphoid salmonellosis in the era of increasing antibiotic resistance.
The authors prospectively monitored 311 children with nontyphoid salmonellosis in Kaohsiung, Taiwan. The demographic, clinical, and microbiologic features, underlying diseases, treatment regimen, complications, and outcome were analyzed. In vitro susceptibility testing of the isolates was performed.
The median age of affected patients was 15 months. Salmonella enteritidis B caused 68.5% of episodes, followed by S. enteritidis C1 (11.9%), D (7.7%), C2 (7.1%), E (2.6%), S. choleraesuis (1.6%), and S. paratyphi (0.6%). Sixty percent of isolates were resistant to ampicillin. Patients with bacteremia could not be differentiated from patients without bacteremia on clinical grounds. Patients receiving antibiotics that were inactive in vitro (discordant therapy) had more days of fever and longer hospital stay compared with patients receiving antibiotics that were active in vitro (concordant therapy). Patients receiving no antibiotic treatment had the fewest days of fever and shortest hospital stays, especially among patients with mild illness (severity score, 0-1).
Blood culture should be obtained in patients with nontyphoid salmonellosis to detect bacteremia. In treating antibiotic-resistant nontyphoid salmonellosis, antibiotics are still not mandatory for patients who present with primarily gastrointestinal symptoms and limited signs of systemic inflammation reflected by a low severity score (low C-reactive protein, fewer band cells in peripheral blood, and fewer days of fever before admission). Susceptibility data should be promptly obtained because use of discordant antibiotics appears to prolong illness.
本研究旨在调查非伤寒沙门菌感染患者的流行病学、临床和微生物学特征,并阐明耐药性对台湾非伤寒沙门菌感染预后的影响。作者还试图制定一个严重程度评分系统,以便在抗生素耐药性不断增加的时代,为非伤寒沙门菌感染的抗生素使用提供客观指导。
作者前瞻性监测了台湾高雄市311例非伤寒沙门菌感染儿童。分析了患者的人口统计学、临床和微生物学特征、基础疾病、治疗方案、并发症及预后。对分离菌株进行了体外药敏试验。
受影响患者的中位年龄为15个月。肠炎沙门菌B型引起68.5%的感染,其次是肠炎沙门菌C1型(11.9%)、D型(7.7%)、C2型(7.1%)、E型(2.6%)、猪霍乱沙门菌(1.6%)和副伤寒沙门菌(0.6%)。60%的分离菌株对氨苄西林耐药。菌血症患者与无菌血症患者在临床上无法区分。与接受体外敏感抗生素治疗(一致治疗)的患者相比,接受体外不敏感抗生素治疗(不一致治疗)的患者发热天数更多,住院时间更长。未接受抗生素治疗的患者发热天数最少,住院时间最短,尤其是病情较轻(严重程度评分0 - 1)的患者。
非伤寒沙门菌感染患者应进行血培养以检测菌血症。在治疗耐药性非伤寒沙门菌感染时,对于主要表现为胃肠道症状且严重程度评分较低(低C反应蛋白、外周血杆状核细胞较少、入院前发热天数较少)反映全身炎症体征有限的患者,抗生素并非必需。应及时获取药敏数据,因为使用不敏感抗生素似乎会延长病程。